BioStem Technologies BSEM Ratios (2024-2026)

NASDAQ BSEM
$1.47 +0.43 (+41.35%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

BioStem Technologies Quarterly Ratios

Periods 6 quarters
Latest Jun 2026

BioStem Technologies reported a gross margin of 61.28% and a net margin of -113.57% for the quarter ended Jun 2026. These financial ratios cover 6 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2024 Mar2025 Jun2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin 94.65%93.75%61.27%61.28%
EBT Margin 33.07%1.62%-143.75%-113.57%
EBIT Margin 32.88%1.03%-144.80%-106.35%
EBITDA Margin 33.37%1.94%-135.15%-96.93%
Operating Margin 32.88%1.03%-144.80%-106.35%
Net Margin 24.48%0.10%-143.75%-113.57%
FCF Margin 26.55%43.42%-13.43%-70.87%
Efficiency
Inventory AverageInventory Avg. 3.69M4.61M
Assets AverageAssets Avg. 52.55M51.95M
Equity AverageEquity Avg. 43.06M46.66M43.19M35.50M29.74M
Invested CapitalInvested Cap. 44.13M42.14M34.87M28.61M
Asset Utilization RatioAsset Util. 0.79
Leverage & Solvency
Debt Ratio 0.070.060.050.02
Valuation
Price to SalesP/S 1.44
Price to BookP/B 5.763.124.551.642.152.13
Enterprise Value 207.76M143.71M215.15M34.56M54.74M51.91M
Market Capitalization 230.59M143.71M215.15M64.11M68.45M58.87M
Price to FCFP/FCF 22.84
EV to FCF 20.14
EV to CFO 16.57
Return Ratios
Return on Sales [ROS]ROS 32.88%1.03%-144.80%-106.35%
Return on Capital Employed [ROCE]ROCE -38.78%
Return on Assets [ROA]ROA -21.42%
Return on Equity [ROE]ROE -37.41%

BioStem Technologies Ratios API

Pull BioStem Technologies's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BSEM&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY